EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment

J. S. Whelan, S. S. Bielack, N. Marina, S. Smeland, G. Jovic, J. M. Hook, M. Krailo, J. Anninga, T. Butterfass-Bahloul, Tom Böhling, G. Calaminus, M. Capra, C. Deffenbaugh, C. Dhooge, M. Eriksson, A. M. Flanagan, H. Gelderblom, A. Goorin, R. Gorlick, G. GoshegerR. J. Grimer, K. S. Hall, K. Helmke, P. C.W. Hogendoorn, G. Jundt, L. Kager, T. Kuehne, C. C. Lau, G. D. Letson, J. Meyer, P. A. Meyers, C. Morris, H. Mottl, H. Nadel, R. Nagarajan, R. L. Randall, P. Schomberg, R. Schwarz, L. A. Teot, Matthew R. Sydes, M. Bernstein, James Pickering, Nicola Joffe, Matthias Kevric, Benjamin Sorg, Doojduen Villaluna, Caroline Wang, Martha Perisoglou, Leonardo Trani, Jenny Potratz, Dorothe Carrle, Miriam Wilhelm, Katja Zils, Carmen Teske

    Research output: Contribution to journalArticlepeer-review

    214 Scopus citations

    Abstract

    This manuscript describes the experience from registration until randomisation for a cohort of 2260 patients with osteosarcoma who joined the EURAMOS-1 trial. This includes pre-operative chemotherapy and surgery. It sets out the practical issues in collaboration and in achieving randomisation.

    Original languageEnglish (US)
    Pages (from-to)407-414
    Number of pages8
    JournalAnnals of Oncology
    Volume26
    Issue number2
    DOIs
    StatePublished - Feb 1 2015

    Keywords

    • International collaboration
    • Osteosarcoma
    • Randomised controlled trial
    • Trial conduct

    ASJC Scopus subject areas

    • Hematology
    • Oncology

    Fingerprint

    Dive into the research topics of 'EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment'. Together they form a unique fingerprint.

    Cite this